HomeInsights52 Week Low Stocks

Parmax Pharma Ltd 52 Week Low

Parmax Pharma Ltd 52 Week Low

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Dec 20, 2024)

stocks purchased

1.8 K

Stocks Traded

(Dec 20, 2024)

Last Updated on: Dec 22, 2024

Image

Parmax Pharma Ltd

NSE: PARMAXPHARMA

YEARLOW

₹ 24.18

Last updated on: Dec 20, 2024

Key Highlights

  • The 52 Week Low of Parmax Pharma Ltd is ₹ 24.18 as of 20 Dec 24 .

Company Fundamentals for Parmax Pharma Ltd

No data available

Market Price of Parmax Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Parmax Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
20 Dec 202443.7
19 Dec 202446
18 Dec 202443.84
17 Dec 202446.08
16 Dec 202448.5
13 Dec 202447
12 Dec 202445
11 Dec 202445.28
10 Dec 202444.75
09 Dec 202447.1

Asset Value vs Market Value of Parmax Pharma Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Parmax Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Parmax Pharma Ltd

No data available

* All values are in crore

Parmax Pharma Ltd News Hub

News

Parmax Pharma to discuss results

Parmax Pharma will hold a meeting of the Board of Directors of the Company on 14 November ...

Read more

07 Nov 2024 11:45

News

Parmax Pharma to conduct AGM

Parmax Pharma announced that the Annual General Meeting (AGM) of the company will be held ...

Read more

18 Sep 2024 16:46

News

Parmax Pharma to declare Quarterly Result

Parmax Pharma will hold a meeting of the Board of Directors of the Company on 14 August 20...

Read more

09 Aug 2024 14:53

News

Parmax Pharma revises board meeting date

Parmax Pharma has revised the meeting of the Board of Directors which was scheduled to be ...

Read more

29 May 2024 12:10

News

Parmax Pharma schedules board meeting

Parmax Pharma will hold a meeting of the Board of Directors of the Company on 28 May 2024 ...

Read more

24 May 2024 12:53

News

Parmax Pharma to hold board meeting

Parmax Pharma will hold a meeting of the Board of Directors of the Company on 14 February ...

Read more

09 Feb 2024 16:10

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week Low of Parmax Pharma Ltd

Why is it important to track the 52-week low of Parmax Pharma Ltd stocks?

Investors should monitor the 52-week low of Parmax Pharma Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Parmax Pharma Ltd stocks hitting a 52-week low?

Factors leading to Parmax Pharma Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Parmax Pharma Ltd stocks when they hit a 52-week low?

Buying Parmax Pharma Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Parmax Pharma Ltd stocks?

Investors should monitor the 52-week low of Parmax Pharma Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Parmax Pharma Ltd stock at their 52-week low?

An investor can analyze the reasons for the Parmax Pharma Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Parmax Pharma Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Parmax Pharma Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Parmax Pharma Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions